Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hawkins

Showing results (41-50 of 580) with videos related to

Pageof 58
Sort By:
Clinical and Experimental Immunology|August 1, 1990
A primed state exists in vivo following histological regression of amyloidosisP N Hawkins, M B Pepys
The Journal of Clinical Investigation|October 17, 2017
Cannabis in fat: high hopes to treat obesityMelody N Hawkins, Tamas L Horvath
The New England Journal of Medicine|April 30, 2015
V122I transthyretin variant in elderly black AmericansJulian D Gillmore, Philip N Hawkins
Nature Clinical Practice. Nephrology|August 26, 2006
Drug Insight: emerging therapies for amyloidosisJulian D Gillmore, Philip N Hawkins
Oncology (Williston Park, N.Y.)|April 12, 2012
AL amyloidosis: new drugs and tests, but old challengesAshutosh D Wechalekar, Philip N Hawkins
Nature Reviews. Nephrology|August 28, 2013
Pathophysiology and treatment of systemic amyloidosisJulian D Gillmore, Philip N Hawkins
Blood|October 23, 2004
The role of PBSCT in treatment of AL amyloidosis is far from settledHugh J B Goodman, Philip N Hawkins
Global Heart|November 29, 2023
Standardising Care and Treatment of Transthyretin Amyloid CardiomyopathyMarianna Fontana, Aldostefano Porcari, Philip N Hawkins
Skin Therapy Letter|July 24, 2008
Novel topical drug delivery systems and their potential use in acne vulgarisM Taglietti, C N Hawkins, J Rao
Digestive Diseases and Sciences|July 26, 2006
Amyloidosis and primary biliary cirrhosis, Rodriguez-Luna et alHugh J B Goodman, Philip N Hawkins
Pageof 58

Showing results (41-50 of 580) with videos related to

Sort By:
Pageof 58
Clinical and Experimental Immunology|August 1, 1990
A primed state exists in vivo following histological regression of amyloidosisP N Hawkins, M B Pepys
The Journal of Clinical Investigation|October 17, 2017
Cannabis in fat: high hopes to treat obesityMelody N Hawkins, Tamas L Horvath
The New England Journal of Medicine|April 30, 2015
V122I transthyretin variant in elderly black AmericansJulian D Gillmore, Philip N Hawkins
Nature Clinical Practice. Nephrology|August 26, 2006
Drug Insight: emerging therapies for amyloidosisJulian D Gillmore, Philip N Hawkins
Oncology (Williston Park, N.Y.)|April 12, 2012
AL amyloidosis: new drugs and tests, but old challengesAshutosh D Wechalekar, Philip N Hawkins
Nature Reviews. Nephrology|August 28, 2013
Pathophysiology and treatment of systemic amyloidosisJulian D Gillmore, Philip N Hawkins
Blood|October 23, 2004
The role of PBSCT in treatment of AL amyloidosis is far from settledHugh J B Goodman, Philip N Hawkins
Global Heart|November 29, 2023
Standardising Care and Treatment of Transthyretin Amyloid CardiomyopathyMarianna Fontana, Aldostefano Porcari, Philip N Hawkins
Skin Therapy Letter|July 24, 2008
Novel topical drug delivery systems and their potential use in acne vulgarisM Taglietti, C N Hawkins, J Rao
Digestive Diseases and Sciences|July 26, 2006
Amyloidosis and primary biliary cirrhosis, Rodriguez-Luna et alHugh J B Goodman, Philip N Hawkins
Pageof 58